Department of Cell Biology, Center for Cell Dynamics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Beirut, Lebanon.
Cancer Res. 2020 Jan 15;80(2):204-218. doi: 10.1158/0008-5472.CAN-18-3241. Epub 2019 Nov 1.
Dissemination is an essential early step in metastasis but its molecular basis remains incompletely understood. To define the essential targetable effectors of this process, we developed a 3D mammary epithelial culture model, in which dissemination is induced by overexpression of the transcription factor Twist1. Transcriptomic analysis and ChIP-PCR together demonstrated that protein kinase D1 (Prkd1) is a direct transcriptional target of Twist1 and is not expressed in the normal mammary epithelium. Pharmacologic and genetic inhibition of Prkd1 in the Twist1-induced dissemination model demonstrated that Prkd1 was required for cells to initiate extracellular matrix (ECM)-directed protrusions, release from the epithelium, and migrate through the ECM. Antibody-based protein profiling revealed that Prkd1 induced broad phosphorylation changes, including an inactivating phosphorylation of β-catenin and two microtubule depolymerizing phosphorylations of Tau, potentially explaining the release of cell-cell contacts and persistent activation of Prkd1. In patients with breast cancer, and expression correlated with metastatic recurrence, particularly in basal breast cancer. Prkd1 knockdown was sufficient to block dissemination of both murine and human mammary tumor organoids. Finally, knockdown blocked primary tumor invasion and distant metastasis in a mouse model of basal breast cancer. Collectively, these data identify Prkd1 as a novel and targetable signaling node downstream of Twist1 that is required for epithelial invasion and dissemination. SIGNIFICANCE: Twist1 is a known regulator of metastatic cell behaviors but not directly targetable. This study provides a molecular explanation for how Twist1-induced dissemination works and demonstrates that it can be targeted. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/2/204/F1.large.jpg.
传播是转移的一个重要早期步骤,但它的分子基础仍不完全清楚。为了确定这个过程中必需的可靶向效应物,我们开发了一种 3D 乳腺上皮培养模型,其中通过过表达转录因子 Twist1 诱导传播。转录组分析和 ChIP-PCR 共同表明,蛋白激酶 D1(Prkd1)是 Twist1 的直接转录靶点,在正常乳腺上皮中不表达。在 Twist1 诱导的传播模型中,Prkd1 的药理学和遗传学抑制表明,Prkd1 是细胞开始细胞外基质(ECM)定向突起、从上皮细胞释放和通过 ECM 迁移所必需的。基于抗体的蛋白质分析显示,Prkd1 诱导广泛的磷酸化变化,包括β-catenin 的失活磷酸化和 Tau 的两个微管解聚磷酸化,这可能解释了细胞-细胞接触的释放和 Prkd1 的持续激活。在乳腺癌患者中, 和 的表达与转移性复发相关,特别是在基底乳腺癌中。Prkd1 敲低足以阻断鼠和人乳腺肿瘤类器官的传播。最后,在基底乳腺癌的小鼠模型中, 敲低 足以阻断原发性肿瘤侵袭和远处转移。总的来说,这些数据表明 Prkd1 是 Twist1 下游的一个新的可靶向信号节点,它是上皮侵袭和传播所必需的。意义:Twist1 是已知的转移性细胞行为的调节因子,但不能直接靶向。本研究为 Twist1 诱导的传播机制提供了分子解释,并证明它可以作为靶点。